← signals
2026-08-08·SMIC·foundry technology lag
lowdown

Prediction markets consistently assign a low probability to SMIC outcompeting TSMC in semiconductor manufacturing.

Prediction markets consistently assign a low probability to SMIC outcompeting TSMC in semiconductor manufacturing.

window 90devidence 3confidence score 91price 0981.HK $66.20

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

0981.HK has already moved down -17% over the recent 30-90 day window.

partly priced
as of 2026-08-107d n/a45d n/a90d -14%yahoo

signal brief

Prediction markets consistently assign a low probability to SMIC outcompeting TSMC in semiconductor manufacturing. The consensus for success by 2024 is 4.61%, by 2028 is 11.64%, and by 2033 is only 15.37%. These figures suggest that even over a ten-year horizon, traders do not expect SMIC (or Chinese leading-edge fabs) to match TSMC's process technology and yield. This has direct implications for global AI supply chains: advanced AI accelerators will continue to rely on TSMC (and possibly Intel/Samsung) for the foreseeable future. For SMIC, the low probability is a bearish indicator on its competitive trajectory and its ability to serve high-performance AI chip demand. It also underscores the durability of TSMC's foundry moat despite export controls and efforts to boost domestic Chinese capacity.

What the sources said:

  • 'Manifold consensus on "Will China's SMIC manage to manufacture semiconductors that will outcompete Taiwan's TSMC by the end of 2033?": YES=15.37%' — Manifold
  • 'Manifold consensus on "Will China's SMIC manage to manufacture semiconductors that will outcompete Taiwan's TSMC by the end of 2028?": YES=11.64%' — Manifold
  • 'Manifold consensus on "Will China's SMIC manage to manufacture semiconductors that will outcompete Taiwan's TSMC by the end of 2024?": YES=4.61%' — Manifold

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.